SCHEMBL3974016

SCHEMBL3974016

CNCCc1oc2ccccc2c1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
MTNR1A P48039 1/20 0.42
MTNR1B P49286 1/20 0.42
TAAR1 Q96RJ0 4/20 0.41
ATM Q13315 1/20 0.41
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 2/20 0.39
HTR1A P08908 1/20 0.39
HTR2A P28223 1/20 0.39
HTT P42858 1/20 0.39
MAPT P10636 2/20 0.38
USP2 O75604 1/20 0.38
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
KCNH2 Q12809 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1252145 0.82 KCNH2 (0.43) NPC1RAB9AMTNR1AMTNR1BKDM4E
SCHEMBL793212 0.80 CYP2C9 (0.48) NPC1RAB9AKDM4EKCNH2
Lithium Ion SCHEMBL29799795 0.79 KCNH2 (0.41) NPC1RAB9AMTNR1AMTNR1BKDM4E
SCHEMBL5071044 0.79 KDM4E (0.43) NPC1RAB9AKDM4EALDH1A1HTT
Lithium Ion SCHEMBL27238876 0.78 KCNH2 (0.40) NPC1RAB9AMTNR1AMTNR1BKDM4E
SCHEMBL6718612 0.77 PTPN1 (0.56) NPC1
SCHEMBL5335011 0.76 PTPN1 (0.41) NPC1RAB9AKDM4EALDH1A1MAPT
SCHEMBL10238814 0.76 CYP2C19 (0.49) KDM4EALDH1A1HTR1AHTR2AMAPT
SCHEMBL14387039 0.75 PTPN1 (0.50) MAPT
SCHEMBL4742417 0.74 KDM4E (0.42) NPC1RAB9AKDM4EALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054422-A1 ACRYLAMIDE DERIVATIVES AS FAB I INHIBITORS Affinium Pharmaceuticals, Inc. (CA) 2009-05-06 EP disclosed
EP-1973902-A2 3-HETEROCYCLYLACRYLAMIDE COMPOUNDS AS FABI INHIBITORS AND ANTIBACTERIAL AGENTS Affinium Pharmaceuticals, Inc. (CA) 2008-10-01 EP disclosed
WO-2008009122-A1 ACRYLAMIDE DERIVATIVES AS FAB I INHIBITORS AFFINIUM PHARMACEUTICALS, INC. (CA) 2008-01-24 WO disclosed
WO-2007067416-A2 HETEROCYCLYLACRYLAMIDE COMPOUNDS AS FABI INHIBITORS AND ANTIBACTERIAL AGENTS AFFINIUM PHARMACEUTICALS, INC. (CA) 2007-06-14 WO disclosed